Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Chemotherapy and Pharmacology|May 22, 2016
Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomasMichael J Nathenson, Edward Sausville
Biomedical Chromatography : BMC|September 14, 2002
A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasmaSuoping Zhai, Edward Sausville, William D Figg
The Oncologist|September 23, 2017
Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone SarcomasMichael J Nathenson, Anthony P Conley, Edward Sausville
Cancer Chemotherapy and Pharmacology|November 26, 2014
Autophagy modulation: a target for cancer treatment developmentAlison Duffy, Jackson Le, Edward Sausville, et al.
Statistics in Medicine|January 12, 2008
Experimental design and interaction analysis of combination studies of drugs with log-linear dose responsesHong-Bin Fang, Douglas D Ross, Edward Sausville, et al.
Neoplasia (New York, N.Y.)|July 20, 2005
Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myelomaTamer E Fandy, Sharmila Shankar, Douglas D Ross, et al.
Bioorganic & Medicinal Chemistry|June 28, 2005
Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activationYuehai Shen, Qian Xie, Monica Norberg, et al.
Cancer Research|June 17, 2005
DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cellsLing-hua Meng, Glenda Kohlhagen, Zhi-yong Liao, et al.
World Journal of Surgical Oncology|October 13, 2018
Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcomaMichael J Nathenson, Constance M Barysauskas, Robert A Nathenson, et al.
Plos One|August 18, 2017
Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized miceSandra Medina-Moreno, Thomas C Dowling, Juan C Zapata, et al.
Pageof 2